J. Pearlman

Most-cited papers

1. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

   R. Avery, J. Pearlman, D. Pieramici, M. Rabena +5 more

   2006Ophthalmology (Rochester, Minn.)792 citations

   Semantic Scholar

   Save

2. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

   Yosef Koronyo, D. Biggs, E. Barrón, D. Boyer +13 more

   2017JCI Insight491 citations Open access

   Semantic Scholar

   Save

3. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.

   G. Jaffe, K. Westby, K. Csaky, J. Monés +6 more

   2020Ophthalmology (Rochester, Minn.)433 citations Open access

   Semantic Scholar

   Save

4. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.

   P. Campochiaro, R. Sophie, J. Pearlman, David M. Brown +5 more

   2014Ophthalmology (Rochester, Minn.)366 citations Open access

   Semantic Scholar

   Save

5. Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab

   A. Witkin, P. Hahn, T. Murray, J. F. Arevalo +9 more

   2020Journal of VitreoRetinal Diseases177 citations Open access

   Semantic Scholar

   Save

6. MORPHOMETRIC ANALYSIS OF THE MACULA IN EYES WITH DISCIFORM AGE-RELATED MACULAR DEGENERATION

   S. Y. Kim, S. Sadda, J. Pearlman, M. Humayun +3 more

   2002Retina168 citations

   Semantic Scholar

   Save

7. Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial.

   G. Jaffe, T. Ciulla, A. Ciardella, F. Devin +9 more

   2017Ophthalmology (Rochester, Minn.)144 citations Open access

   Semantic Scholar

   Save

8. Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial.

   P. Rosenfeld, P. Dugel, F. Holz, J. Heier +6 more

   2018Ophthalmology (Rochester, Minn.)118 citations Open access

   Semantic Scholar

   Save

9. Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration.

   P. Dugel, D. Boyer, Andrew N. Antoszyk, N. Steinle +6 more

   2019Ophthalmology Retina53 citations Open access

   Semantic Scholar

   Save

10. Brolucizumab-associated intraocular inflammation in eyes without retinal vasculitis

    A. Witkin, P. Hahn, T. Murray, J. F. Arevalo +9 more

    2020Journal of VitreoRetinal Diseases37 citations Open access

    Semantic Scholar

    Save

11. Randomized Trial of Biosimilar XSB-001 Versus Reference Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.

    A. Loewenstein, N. Czumbel, J. Ernest, J. Dusová +2 more

    2023Ophthalmology Retina19 citations Open access

    Semantic Scholar

    Save

12. Clinical Ophthalmology Dovepress Combination Verteporfin Photodynamic Therapy Ranibizumab-dexamethasone in Choroidal Neovascularization Due to Age-related Macular Degeneration: Results of a Phase Ii Randomized Trial on Behalf of the Radical Trial Group

    R. Gallemore, Josh Wallsh, H. Hudson, A. Ho +2 more

    12 citations

    Semantic Scholar

    Save

13. Multifocal choroiditis and panuveitis presenting with progressive equatorial linear streaks: evolution of Schlaegel lines documented with multimodal imaging.

    Thanapong Somkijrungroj, J. Pearlman, J. Gonzales

    2015Retinal cases & brief reports10 citations

    Semantic Scholar

    Save

14. Unexplained vision loss following removal of epiretinal membrane

    R. Roe, H. McDonald, Arthur D. Fu, J. Lahey +7 more

    2010British Journal of Ophthalmology9 citations

    Semantic Scholar

    Save

15. Re: Chew et al.: Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test? (Ophthalmology 2015;122:212-5).

    J. Pearlman

    2015Ophthalmology (Rochester, Minn.)8 citations

    Semantic Scholar

    Save

16. Private equity ownership of ophthalmology practices: how does it impact clinical research?

    Margaret A. Chang, J. Pearlman

    2022Current Opinion in Ophthalmology1 citations

    Semantic Scholar

    Save

17. Private Equity: A Punctuated Equilibrium in Retina

    J. Pearlman

    2023Journal of VitreoRetinal Diseases0 citations Open access

    Semantic Scholar

    Save

18. Reply.

    G. Jaffe, K. Westby, K. Csaky, J. Monés +6 more

    2021Ophthalmology (Rochester, Minn.)0 citations

    Semantic Scholar

    Save

19. Reply.

    G. Jaffe, K. Westby, Karl G. Csaky, J. Monés +6 more

    2021Ophthalmology (Rochester, Minn.)0 citations

    Semantic Scholar

    Save

20. Acute Severe Visual Acuity Decrease After Combination Therapy for Wet Macular Degeneration

    J. B. Davies, G. Shah, K. Blinder, E. Ryan +6 more

    20080 citations

    Semantic Scholar

    Save

21. Endogenous Endophthalmitis: A 17–Year Review of Cases At an Academic Hospital

    J. Pearlman, M. Gill

    20050 citations

    Semantic Scholar

    Save

22. A Retrospective Analysis of Macular Hole Repair in Patients with Pre–existing Glaucoma

    S. Adrean, N. Khodadadi, J. Pearlman, R. Wendel +3 more

    20040 citations

    Semantic Scholar

    Save

23. Influence of high fat diet on severity of choroidal neovascularization and apoptosis in a murine model

    E. N. Martins, S. Oltjen, J. Pearlman, L. Hjelmeland +1 more

    20040 citations

    Semantic Scholar

    Save

24. Intravenous Versus Intravenous Antibiotics for the Prophylaxis of Postraumatic Endophthalmitis

    M. Blair, J. Pearlman, J. Harlan, M. Siler

    20020 citations

    Semantic Scholar

    Save